Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Market Cap	40.44B
Revenue (ttm)	13.56B
Net Income (ttm)	1.61B
Shares Out	91.67M
EPS (ttm)	17.56
PE Ratio	25.12
Forward PE	20.64
Dividend	4.50 (1.02%)
Ex-Dividend Date	Sep 13, 2024

Volume	140,782
Average Volume	206,468
Open	450.10
Previous Close	448.65
Day's Range	440.00 - 453.00
52-Week Range	211.30 - 572.00
Beta	0.58
RSI	59.65
Earnings Date	May 21, 2025

About NSE:INDRAMEDCO

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 2,977
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDRAMEDCO

Financial Performance

In 2024, NSE:INDRAMEDCO's revenue was 13.56 billion, an increase of 8.97% compared to the previous year's 12.45 billion. Earnings were 1.61 billion, an increase of 29.87%.